ezetimibe has been researched along with Active Hyperemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kobayashi, T; Kurozumi, A; Masuda, D; Mori, H; Okada, Y; Tanaka, Y; Yamashita, S | 1 |
| Enko, K; Ito, H; Kohno, K; Kusano, KF; Miyoshi, T; Morita, H; Nakamura, K; Yunoki, K | 1 |
2 trial(s) available for ezetimibe and Active Hyperemia
| Article | Year |
|---|---|
Detrimental effects of high-fat diet loading on vascular endothelial function and therapeutic efficacy of ezetimibe and statins in patients with type 2 diabetes.
Topics: Adult; Aged; Atherosclerosis; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Diet, High-Fat; Dietary Fats; Endothelium, Vascular; Ezetimibe; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperemia; Hyperlipidemias; Male; Middle Aged; Pilot Projects; Postprandial Period; Treatment Outcome | 2016 |
Ezetimibe improves postprandial hyperlipemia and its induced endothelial dysfunction.
Topics: Adult; Azetidines; Biomarkers; Endothelium, Vascular; Ezetimibe; Fasting; Female; Humans; Hyperemia; Hyperlipidemias; Hypolipidemic Agents; Japan; Lipids; Male; Middle Aged; Postprandial Period; Prospective Studies; Time Factors; Treatment Outcome; Vasodilation | 2011 |